BackMyovant Sciences Overview

Myovant Sciences Research & Development

Research & Development expenses for MYOV.

Quarterly R&D Expenses

$31.52M
↑ 22.51% YoY

As of Dec 31, 2022

Annual R&D Expenses (TTM)

$106.84M
↑ 2.3% YoY

Trailing 12 months ending Dec 31, 2022

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin